Expression of Concern: Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study
Transplant International Editorial OfficeAn Expression of Concern on
Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study
by Raval AD, Ganz ML, Fraeman K, Lorden AL, Saravanan S, Tang Y and Santos CAQ (2022) Transpl. Int. 35:10528. doi: 10.3389/ti.2022.10528
With this notice, Transplant International states its awareness of concerns as raised by the authors regarding the data validity of “Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study” published on 12 August 2022. While a revised version is currently being conducted by the authors in collaboration with the Editorial Office, this expression of concern has been posted while Transplant International awaits the revisions. It will be updated accordingly after that time.
UPDATE: This article has now been corrected. Please find the full corrigendum here: 10.3389/ti.2024.11921.
Citation: Transplant International Editorial Office (2023) Expression of Concern: Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study. Transpl Int 36:12367. doi: 10.3389/ti.2023.12367
Received: 03 November 2023; Accepted: 03 November 2023;
Published: 10 November 2023.
Copyright © 2023 Transplant International Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Transplant International Editorial Office, ti@frontierspartnerships.org
